Diseño, validación y aplicación clínica de un cuestionario de conocimiento (ConocEAP) de los pacientes con enfermedad arterial periférica

A Scoping Review of Measurement Tools Evaluating Awareness and Disease-Related Knowledge in Peripheral Arterial Disease Patients

“…Table 1 summarizes the characteristics of the included studies. Of the 16 studies included in the review, 13 were quantitative (12 cross-sectional and 1 prospective cohort study) [ 11 , 17 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ] and three were qualitative in design [ 21 , 22 , 40 ]. Two were abstract-only publications [ 35 , 38 ].…”

“…Eleven studies were conducted in the European Region [ 17 , 21 , 22 , 29 , 30 , 31 , 32 , 33 , 38 , 40 ], three in the Region of the Americas [ 11 , 35 , 39 ] and two in the South-East Asian Region [ 34 , 37 ]. Except for one study published in Korean [ 26 ] and one in Spanish [ 36 ], all others were published in English. As shown in Table 1 , the first study was published in 2003 [ 39 ].…”

“…Of the 13 studies that used questionnaires to assess the knowledge and awareness of PAD patients, three (23.1%) evaluated measurement properties: content validity [ 37 ], reproducibility [ 37 ], and internal consistency [ 33 , 36 ]. Following COSMIN, all properties evaluated were considered acceptable ( Table 2 ).…”

“…Overall, disease-related knowledge and awareness in PAD patients were measured with regard to signs/symptoms and complications in twelve instruments ( Figure 2 ) [ 11 , 21 , 22 , 29 , 31 , 32 , 33 , 36 , 37 , 38 , 39 , 40 ], risk factors in nine instruments ( Figure 3 ) [ 11 , 21 , 22 , 29 , 30 , 31 , 36 , 38 , 40 ], pathophysiology in eight instruments ( Figure 4 ) [ 11 , 29 , 31 , 32 , 36 , 37 , 38 , 40 ], and management and pharmacological therapy in six instruments ( Figure 5 ) [ 31 , 35 , 36 , 38 , 39 , 40 ]. One of the studies presented general knowledge without describing specific areas [ 34 ].…”

“…Among PAD signs/symptoms, four studies included knowledge questions about intermittent claudication. Of these, two studies reported the percentage of participants who identified intermittent claudication as a PAD sign or symptom (21.0% and 47.1%) [ 21 , 36 ] and two studies showed that patients did not effectively recognize intermittent claudication as a symptom of PAD [ 22 , 40 ]. Knowledge about other complications related to PAD was also included as the following: coronary artery disease/heart attack ( n = 5 studies; median % of patients who identified this PAD complication = 65.7%; range = 58.8% to 77.0%) [ 11 , 29 , 31 , 33 , 38 ], stroke ( n = 5; median % = 58.8%; range = 28.7% to 71.0%) [ 11 , 29 , 33 , 38 , 39 ], death ( n = 4; median = 59.1%; range = 26.6% to 84.0%) [ 11 , 29 , 33 , 39 ], inability to walk ( n = 3; median = 84.0%; range = 80.0% to 85.7%) [ 11 , 29 , 33 ], amputation ( n = 3; median = 78.0%; range = 73.2% to 91.0%) [ 11 , 29 , 33 ], leg pain ( n = 2; median = 86.4%; range = 85.7% to 87.0%) [ 11 , 33 ], and ulcers ( n = 1; 76.0% participants identified this PAD complication) [ 33 ].…”